Partnerships and collaborations
Collaboration with WHO departments
-
Chronic diseases and Health Promotion (CHP/CPM)
Collaborative approach of strategies for end stage renal disease prevention and management - Corneal transplantation
- Collaborative approach of the risk of pathogen transmission, including zoonosis (CPE/ZKF) and communicable diseases surveillance and Response (CSR).
Collaboration with governmental organizations
- Agence de la biomédecine, Paris France
- US Food and Drug Administration, Centre for Biologics Evaluation and Research, Office of Cellular Tissues and Gene Therapies
- - Tissues (US FDA Cber)
- - Cellular & Gene Therapy (US FDA Cber)
- - Xenotransplantation (US FDA Cber)
- Organizacion Nacional de Trasplantes (ONT) Madrid, Spain
